Cannabis Testing market Professional Survey Report by 2035 The legalization and recent applications of cannabis for the treatment of certain medical conditions has led to the rise in demand for various cannabis-infused products. These products need to be tested thoroughly, in order to maintain regulatory standards and ensure consumer safety. Following this, cannabis testing services are currently being used across several industries, including healthcare, chemical, cosmetic, agriculture and food. The financial opportunity within the cannabis testing market has been analyzed across the following segments:  Type of Cannabis Tested  Medical Cannabis  Recreational / Adult-use Cannabis  Type of Sample Tested  Flowers  Extracts  Edibles  Others  Company Size  Large  Mid-sized  Small  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa The research also includes profiles of key players (listed below) engaged in the cannabis testing market; each profile features a brief overview of the company, details related to its financial information (if available), service portfolio, recent developments, and an informed future outlook.  AccuScience Laboratories  Anresco Labs  CDX Analytics  Coastal Analytical  Eurofins Scientific  EVIO Labs  FoodChain ID  LGC  Medicine Creek Analytics  SGS  Tentamus Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape: Cannabis Testing Service Providers 5. Cannabis Testing Service Providers: Company Competitiveness Analysis 6. Cannabis Testing Service Providers: Company Profiles 7. Market Landscape: Cannabis Testing Product Providers 8. Partnerships and Collaborations 9. Global Event Analysis 10. Cannabis Testing Services Market: Market Sizing and Opportunity Analysis 11. Concluding Remarks 12. Executive Insights 13. Appendix 1: Tabulated Data 14. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link: https://www.rootsanalysis.com/reports/cannabis-testing-market.html News article Non-viral Transfection Reagents and Systems Market Learn from experts: do you know about these emerging industry trends? mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends Novel Cell Cytometers: Need of the Hour Learn from our recently published whitepaper: - Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com #cannabistesting #cannabistestingservicesmarket #medicalcannabistesting #MarketResearch #MarketInsights

Conjugation and Labeling Services market Professional Survey Report by 2035 The complexities associated with conjugation of biomolecules and the need for click-chemistry expertise have prompted the pharmaceutical industry to rely on conjugation and labeling service providers Roots Analysis is pleased to announce the publication of its recent study, titled, “Conjugation and Labeling Services Market, 2023-2035” The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies. Amongst other elements, the report includes  An executive summary of the insights captured during our research. It offers a high-level view on the current state of conjugation and labeling services market and its likely evolution in the mid-long term.  A general overview of conjugation and labeling of biomolecules, highlighting the various advantages of biomolecule conjugation and labeling. It also provides details on the different types of biomolecular conjugates and labels.  A detailed assessment of the overall market landscape of the companies offering conjugation and labeling services.  A company competitiveness analysis of conjugation and labeling service providers.  Elaborate profiles of prominent players offering conjugation and labeling services (shortlisted based on a proprietary criterion).  A detailed analysis of the recent partnerships inked between stakeholders engaged in this domain, since 2018.  A detailed analysis of recent events (webinars / conferences / seminars / meetings / symposiums / summits) that were organized for stakeholders in the bioconjugation domain.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Type of Molecule  Proteins  Peptides  Small Molecules  Antibodies  Other Molecules  Type of Molecular Conjugate / Label  Polymers  Haptens  Enzymes  Fluorescent Tags  Bead Coupling / Particle Conjugates  Quantum Dots  Isotopes  Other Molecular Conjugates / Labels  Key Geographical Regions  North America  Europe  Asia-Pacific  Middle East and North Africa  Latin America Key companies covered in the report  AltaBioscience  Bachem  Bio-Synthesis  Cayman Chemical  CliniSciences  Eurogentec  GBI  Mimotopes  Peptide Institute  piCHEM For additional details, please visit https://www.rootsanalysis.com/reports/conjugation-and-labeling-services-market.html News article Biopharmaceutical Filtration Market Learn from experts: do you know about these emerging industry trends? T-cell Immunotherapies: The Future of Modern Cancer Treatments Antiviral Drugs Development: Are we Prepared for the Next Viral Pandemic? Learn from our recently published whitepaper: - Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #bioconjugation #antibodylabeling #proteinlabeling #MarketResearch #MarketInsights

mRNA therapeutics and Vaccines market Growth Analysis and Forecast by 2035 The mRNA therapeutics and vaccines market is currently abuzz with activity; industry players have forged several strategic alliances and received significant financial support from investors. This can be attributed to the various benefits offered by these therapeutic modalities, such as ease of administration, higher biological efficacy, enhanced potent immunogenicity and versatile delivery platforms at reduced toxicity levels. The financial opportunity within the mRNA therapeutics and mRNA vaccines market has been analyzed across the following segments:  Routes of Administration  Intradermal  Intravenous  Intranasal  Others  Therapeutic Area  Infectious Diseases  Oncological Disorders  Other Disorders Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa The mRNA Therapeutics and mRNA Vaccine Market, 2022-2035 report features the following companies, which we identified to be key players in this domain:  Arcturus Therapeutics  BioNTech and Pfizer  CureVac  Gennova  Moderna  Walvax Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Overview 5. Competitive Landscape 6. Company Competitiveness Analysis 7. Drug Profiles 8. Big Pharma Initiatives 9. Start-Up Health Indexing 10. Clinical Trial Analysis 11. Partnerships and Collaborations 12. Funding and Investment Analysis 13. Patent Analysis 14. Market Forecast and Opportunity Analysis 15. Market Forecast and Opportunity Analysis 16. Conclusion 17. Appendix 1: Tabulated Data 18. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/mrna-therapeutics-and-vaccines-market.html News article Biopharmaceutical Filtration Market Learn from experts: do you know about these emerging industry trends? CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications Antiviral Drugs: The Unmet Requirement in the Pharmaceutical Space About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #mrnatherapeuticscompanies #mrnavaccinecompanies #mrnatechnology #MarketResearch #MarketInsights

Dental 3D Printing market Size, Share, Trends by 2035 The popularity of 3D printing technology within the dental industry can be attributed to its ability to print high quality / accurate dental products, including crowns, bridges, dentures, dental implants and surgical guides. Driven by the overall growth of the additive manufacturing (3D printing) industry, and wide adoption of 3D printers in the dental sector, the dental 3D printing market is anticipated to witness a steady growth in the foreseen future. The financial opportunity within the SMOs market has been analyzed across the following segments:  Type of Printing Technology  VAT Polymerization Technology  Powder Bed Fusion Technology  Polyjet Technology  Metal Extrusion Technology  Other Technologies  Application Area  Prosthodontics  Orthodontics  Dental Implants  Other Applications  Type of Printing Material  Resins  Plastics  Metals  Metals  Other Material  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa  Rest of the World The Dental 3D Printing Market, 2022 – 2035 report studies dental 3D printers manufacturers in detail and features the following companies, which we identified to be key players in this domain:  3D Systems  Asiga  BEGO  Carbon  Digital Wax Systems (DWS)  Formlabs  Prodways  Rapid Shape  SprintRay  Stratasys Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape 5. Product Competitive Analysis 6. Company Profiles 7. Partnerships and Collaborations 8. Patent Analysis 9. Bowman Clock Pricing 10. Market Forecast and Opportunity Analysis 11. Concluding Remarks 12. Executive Insights 13. Appendix 1: Tabulated Data 14. Appendix 2: List of Companies And Organizations Get more details on the Dental 3D Printing Market report https://www.rootsanalysis.com/reports/dental-3d-printing-market.html You may also be interested in the following titles: Digital Biomanufacturing Market Deep Learning-based Interoperability: Advanced Neural Networks Mimicking the Human Brain Global Digital Therapeutics Market Roots Analysis Consulting - the preferred research partner for global firms About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #dental3dprinting #dental3dprinter #dental3dprinters #MarketResearch #MarketInsights

Aseptic Fill Finish market Size, Share, Trends by 2035 In pursuit of both time and cost savings, as well as to mitigate the challenges associated with the stringent regulatory compliance, lack of technical expertise and access to advanced equipment, a number of drug developers prefer to outsource operations to benefit from the expertise of service providers, that claim to have the required competence and experience to provide fill / finish services in order to ensure the development of high-quality drug products. The financial opportunity within the aseptic fill finish services market has been analyzed across the following segments:  Type of Molecule  Small molecules  Biologics  Type of Packaging Container  Ampoules  Cartridges  Syringes  Vials  Type of Drug Product  Antibodies  Cell Therapies  Gene Therapies  Oligonucleotides  Recombinant Proteins  Vaccines  Other Drug Products  Target Therapeutic Area  Autoimmune disorders  Oncological Disorders  Cardiovascular Disorders  Infectious Diseases  Other Disorders  Scale Of Operation  Preclinical / Clinical  Commercial  Company Size  Large  Mid-sized  Small  Key Geographical Regions  North America  Europe  Asia-Pacific  Middle East and North Africa  Latin America The Aseptic Fill Finish Market, 2023-2035 report features the following companies, which we identified to be key players in this domain:  BD Biosciences  AbbVie Contract Manufacturing  Aenova  APL  Asymchem  BD Biosciences  BioPharma Solutions  BioReliance  Boehringer Ingelheim BioXcellence  Catalent Biologics  Charles River Laboratories  CordenPharma  Delpharm  Fareva  Fresenius Kabi  GlaxoSmithKline  Hetero Drugs  Intas Pharmaceuticals  Lonza  Patheon  Pfizer CentreOne  Pierre Fabre  PiSA Farmaceutica  Plastikon Healthcare  Recipharm  Samsung Biologics  Sharp Services  Siegfried  Syngene  Takara Bio  Wacker Biotech  Wockhardt  WuXi Biologics Table of Contents 1. PREFACE 2. EXECUTIVE SUMMARY 3. INTRODUCTION 4. ASEPTIC FILL FINISH SERVICE PROVIDERS LANDSCAPE 5. BIOLOGICS FILL / FINISH SERVICE PROVIDERS LANDSCAPE 6. SMALL MOLECULE FILL / FINISH SERVICE PROVIDERS LANDSCAPE 7. COMPANY PROFILES: ASEPTIC FILL / FINISH SERVICE PROVIDERS IN NORTH AMERICA 8. COMPANY PROFILES: ASEPTIC FILL / FINISH SERVICE PROVIDERS IN EUROPE 9. COMPANY PROFILES: ASEPTIC FILL / FINISH SERVICE PROVIDERS IN ASIA-PACIFIC 10. PARTNERSHIPS AND COLLABORATIONS 11. MARKET SIZING AND OPPORTUNITY ANALYSIS 12. CASE STUDY: ROBOTICS IN PHARMACEUTICAL PACKAGING 13. CASE STUDY: READY-TO-USE PACKAGING COMPONENTS FOR ASEPTIC FILL / FINISH 14. CONCLUDING REMARKS 15. EXECUTIVE INSIGHTS 16. APPENDIX 1: TABULATED DATA 17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS To view more details on this report, click on the link https://www.rootsanalysis.com/reports/aseptic-fill-finish-market.html You may also be interested in the following titles: Cannabis Testing Market Deep Learning-based Interoperability: Advanced Neural Networks Mimicking the Human Brain Global Gene Switch Market Roots Analysis Consulting - the preferred research partner for global firms About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #asepticfillfinish #asepticfilling #asepticmanufacturing #MarketResearch #MarketInsights

mRNA Synthesis and Manufacturing Services market Trends, Analysis by 2035 Owing to the recent success and growing pipeline of mRNA-based products in the market, mRNA, as a therapeutic agent, has gained significant traction from the medical community. However, due to challenges, such as high capital requirement, stringent regulations and lack of technical expertise, outsourcing has become a preferred business model and CMOs are upgrading their existing capabilities and service portfolios to meet the increased demand for mRNA-based products. A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Type of Product  Drug substances (APIs)  Drug products (FDFs)  Application Area  mRNA-based vaccines  mRNA-based therapeutics  Therapeutic Area  Infectious diseases  Oncological disorders  Other diseases  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa  Rest of the World The mRNA Synthesis and Manufacturing Services Market (2nd Edition), 2022 – 2035 report features the following companies, which we identified to be key players in this domain:  Aldevron  APExBIO  Biomay  bioSYNTHESIS  CELLSCRIPT  eTheRNA  Eurogentec  Jena Biosciences  New England Biolabs  Thermo Fisher Scientific  TriLink BioTechnologies Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape: mRNA Custom Synthesis Service Providers 5. Company Competitiveness Analysis: mRNA Custom Synthesis Service Providers 6. Market Landscape: mRNA Contract Manufacturing Service Providers 7. Company Competitiveness Analysis: mRNA Contract Manufacturing Service Providers 8. Market Landscape: mRNA Synthesis Kit Providers 9. Product Competitiveness Analysis: mRNA Synthesis Kits 10. Company Profiles: mRNA Synthesis and Manufacturing Service Providers 11. Company Profiles: mRNA Synthesis Kit Providers 12. Clinical Trial Analysis 13. Partnership and Collaborations 14. Likely Partners Analysis 15. Big Pharma Initiatives 16. Market Forecast 17. Appendix 1: Tabulated Data 18. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/mrna-synthesis-and-manufacturing-market.html You may also be interested in the following titles: Pharmaceutical Polymers / Medical Polymers Market Antiviral Drugs Development: Are we Prepared for the Next Viral Pandemic? Medical Device Coatings Market Roots Analysis Consulting - the preferred research partner for global firms About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #mRNAsynthesisservices #mRNAsynthesisandmanufacturingservices #mRNAbasedproducts #MarketResearch #MarketInsights

Digital Twins market 2022 – Industry Growth by 2035 Given the potential of digital twins to replicate the physical world in a digital layout, as well as their ability to provide real-time outputs, while gathering constant inputs from the real-world, such products have generated significant interest within the healthcare domain The USD 29.8 billion (by 2035) financial opportunity within digital twins market has been analyzed across the following segments:  Therapeutic Area  Cardiovascular Disorders  Metabolic Disorders  Orthopedic Disorders  Other Disorders  Type of Digital Twin  Process Twins  System Twins  Whole Body Twins  Body Part Twins  Area of Application  Asset / Process Management  Personalized Treatment  Surgical Planning  Diagnosis  Other Applications  End Users  Pharmaceutical Companies  Medical Device Manufacturers  Healthcare Providers  Patients  Other End Users  Key Geographical Regions  North America  Europe  Asia  Latin America  Middle East and North Africa  Rest of the World The Digital Twins Market, 2022-2035, report features the following companies, which we identified to be key players in this domain:  Babylon  ExactCure  ImmersiveTouch  Navv Systems  ThoughtWire  Unlearn.AI The latest report also provides key insights for Digital Twins Technology and Digital Twins Providers Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape 5. Key Insights 6. Company Competitiveness Analysis 7. Company Profiles 8. Partnerships and Collaborations 9. Funding and Investments Analysis 10. Berkus Start-up Valuation Analysis 11. Market Forecast 12. Conclusion 13. Executive insights 14. Appendix I: Tabulated data 15. Appendix II: List of Companies and Organizations Get more details on the Digital Twins Market report https://www.rootsanalysis.com/reports/digital-twins-market.html You may also be interested in the following titles: Non-Viral / Intracellular Drug Delivery Systems Market Dental 3D Printing Market You may also like to learn what our experts are sharing in Roots educational series: At-home Self-testing: A Giant Leap Towards Transformation in Diagnostic Sector SARM1: A Potential Therapeutic Target For Neurodegenerative Diseases About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #DigitalTwinsMarket #DigitalTwinsMarketGrowth #digitaltwins #digitaltwinmarketsize #digitaltwintechnologycompanies

Exosome Therapeutics market, Size and Share by 2035 Close to 60 players, worldwide, have taken initiatives to develop exosome therapeutics; the market is characterized by the presence of start-ups and small companies, claims Roots Analysis Driven by the development of novel platforms and advanced technologies along with consistent efforts of the stakeholders in research and development of exosome therapeutics which is set to see some FDA approved therapies in this decade A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):  Type of Therapeutic  Allogeneic Therapy  AutologousTherapy  Target Indication(s)  Degenerative Meniscal Injury  Dystrophic Epidermolysis Bullosa  Fistula Perianal  Retinitis Pigmentosa  Therapeutic Area  Dermatological Disorders  Muscoskeletal Disorders  Ophthalmic Diseases  Rectal Disorders  Route of Administration  Fistula Tract  Intra-articular  Intra-ocular  Geography  North America  Europe  Asia-Pacific and Rest of the World The Exosome Therapeutics Market, 2022-2040 report features the following companies, which we identified to be key players in this domain:  Codiak BioSciences  Coya Therapeutics  Curexsys  EV Therapeutics  Evox Therapeutics  SHIFTBIO  AEGLE Therapeutics  AVEM Healthcare  Cellular Biomedicine Group  OBCTCD24  ReNeuron  Stem Cell Medicine Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape 5. Company Profiles 6. Drug Profiles 7. Clinical Trial Analysis 8. Academic Grants Analysis 9. Global Event Analysis 10. Partnerships and Collaborations 11. Funding and Investments 12. Start-up Health Indexing 13. Case Study: Exosome Development and Manufacturing Service Providers 14. Drug Failure Analysis 15. Market Forecast 16. Executive Insights 17. Appendix 1: Tabulated Data 18. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/exosome-therapeutics-market.html You may also be interested in the following titles: Decentralized Clinical Trials / Virtual Clinical Trials Market Global Antibiotics Market You may also like to learn what our experts are sharing in Roots educational series: Antiviral Drugs Development: Are we Prepared for the Next Viral Pandemic? Exploring How Artificial Intelligence Is Transforming Digital Pathology About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com Ben.johnson@rootsanalysis.com #Exosome Therapeutics Market Trends #Exosome Therapeutics Market Growth #exosometherapies #exosometherapies

Investor Series: Opportunities in Women’s Digital Health market Trend and Market Forecast 2035 The increase in adoption of digital solutions, which allow diagnosis and remote monitoring of various disease conditions among women, has resulted in a significant uplift in the investment activity in this sector Roots Analysis is pleased to announce the publication of its recent study, titled, “Investor Series: Opportunities in Women's Digital Health Market”. The report provides detailed information on the women’s digital health market, covering the core and peripheral women’s digital health solutions. It offers a technical and financial perspective on how the opportunity in this domain is likely to evolve, in terms of future business success, over the coming decade. The information in this report has been presented across multiple deliverables, featuring MS Excel sheets (some of which include interactive elements) and a MS PowerPoint deck, which summarizes the key takeaways from the project and insights drawn from the curated data. Amongst other elements, the report includes:  An executive summary of the insights captured during our research.  An introduction to women’s digital health, highlighting some of the key application areas of the FemTech industry.  A detailed analysis of women’s digital health focused companies that were established post-2006.  An assessment of the various products / solutions, offered by the innovator companies.  An informed perspective on the value proposition of the companies captured in the report.  A company competitiveness analysis, which offers a quantitative basis for comparing the strengths / contributions of various industry stakeholders that are involved in providing women’s digital health solutions.  A detailed analysis of the women's digital health funding and women's digital health investment activity that has taken place, since 2011.  An elaborate review of the overall women’s digital health market from a financial perspective, including detailed fundamental and technical analysis.  A key acquisition targets analysis, based on the insights generated during the course of this study.  A case study on the assessment of business risks, based on some of the major risk categories that are usually discussed in the industry.  A case study where investors have exited various women’s digital health-related ventures, offering insights on return on investments received (based on availability of data).  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):  Type of Solution  Applications / Software  Devices  Services  Therapeutic Application Area  Fetal Health  General Wellness  Menstrual Cycle  Pelvic Care  Reproductive Health / Fertility  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa The research also includes detailed profiles of the key public ventures engaged in the development of women’s digital health solutions; each profile features a brief overview of the company, details on its management team, insights from its balance sheet (if available), details on its product / service portfolio, recent developments and key financial details (including company investment highlights, company fundamental and company technical analysis). Get more details on the report https://www.rootsanalysis.com/reports/opportunities-in-women-digital--health-market.html You may also be interested in the following titles: Autoinjectors 3D Bioprinting You may also like to learn what our experts are sharing in Roots educational series: SARM1 Inhibitors: A Novel Approach Against Neurodegenerative Disorders TCR Therapies: An Emerging Therapeutic Modality About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #Women’sDigitalHealthInvestorSeries #Women’sDigitalHealthMarket #Digital HealthFunding #women'sdigitalhealthInvestment #women'shealthInvestors

Analysis of TCR Therapy market Strategies and Forecasts to 2035 Given the recent approval of a TCR-based therapy, industry stakeholders have initiated several R&D efforts focused on evaluating the potential of such therapy candidates against various disease indications Roots Analysis is pleased to announce the publication of its recent study, titled, “Global TCR-based Therapy Market (2nd Edition), 2022-2035.” The study features an in-depth analysis of key drivers and trends related to this domain. Amongst other elements, the report includes:  A detailed assessment of the current market landscape of TCR- based therapies.  An analysis of the popular target antigens related to hematological malignancies and solid tumors.  A detailed analysis of completed, ongoing and planned clinical studies related to TCR-based therapies.  An insightful analysis highlighting the key opinion leaders (KOLs) in this domain featuring an analysis of the various principal investigators of clinical trials related to TCR-based therapies.  Elaborate profiles of marketed and mid- to late-stage clinical products (phase I/II or above).  An analysis of various type of partnership that have been inked between several stakeholders in the domain of TCR-based therapies.  An analysis of the investments that have been made into companies that have proprietary TCR-based products / technologies.  An in-depth analysis of patents related to TCR-based therapies, filed / granted till 2022.  A case study on manufacturing cell therapy products, highlighting the key challenges, and a detailed list of contract service providers and in-house manufacturers involved in this space.  An elaborate discussion on various factors that form the basis for the pricing of cell-based therapies.  A review of the key promotional strategies being adopted by the developers of the approved TCR-based therapies.  Elaborate profiles of the several leading players in the domain of TCR cell therapies. A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):  Target Indication(s)  Nasopharyngeal Carcinoma  Multiple Myeloma  Head and Neck Carcinoma  Sarcoma, Melanoma  Acute Myeloid Leukemia  Lung Cancer  Ovarian Cancer  Merkel Cell Cancer  Target Antigen  NY-ESO-1  EBV  gp100  Others  Key Geographical Regions  North America  Europe  Asia Pacific  Latin America  Middle East and North Africa  Rest of the World Transcripts of interviews held with the following senior level representatives of stakeholder companies:  Vincent Brichard (Vice President, Immuno-Oncology, Celyad)  Adrian Bot (Vice President, Scientific Affairs, Kite Pharma)  Victor Lietao Li (Co-Founder and Chief Executive Officer, Lion TCR)  Miguel Forte (Former Chief Operating Officer, TxCell) The research includes profiles of key players (listed below); each profile features a brief overview of the company, details related to its financial information (if available), details about TCR-based product(s), such as information on type of therapy and current development status, information on technology portfolio (if available), recent developments related to TCR therapy and manufacturing capabilities of the players.  Adaptimmune Therapeutics  Alaunos Therapeutics  Bristol Myers Squibb  Cellular Biomedicine Group  Gilead Sciences  GlaxoSmithKline  Immatics  Immunocore  Lion TCR  Takara Bio  Zelluna Immunotherapy To view more details on this report, click on the link: https://www.rootsanalysis.com/reports/tcr-based-therapies-market.html You may also be interested in the following titles: Oral Solid Dosage Manufacturing Market Lipid Nanoparticles in Drug Delivery You may also like to learn what our experts are sharing in Roots educational series: Genotoxicity Testing: Unlocking the Future Safety Assessment Opportunities Adeno-Associated Viral Vectors: Unlocking the Future Opportunities About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com #TCRTherapyMarketSize #TCRTherapyMarketTrends #TCRimmunotherapies #TCRbasedproducts #TCRTherapy

mRNA Synthesis and Manufacturing Services market Share, Growth Analysis by 2035 Given the current technical and operational challenges associated with the manufacturing of mRNA-based products, innovators in the biopharmaceutical industry are increasingly relying on the mRNA synthesis and contract manufacturing service providers Roots Analysis is pleased to announce the publication of its recent study, titled, “mRNA Synthesis and Manufacturing Services Market (2nd Edition), 2022–2035” The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies. Amongst other elements, the report includes  A general overview of mRNA, highlighting details on its structure, the evolution of mRNA vaccines, manufacturing processes and commonly outsourced manufacturing operations.  A detailed assessment of the overall market landscape of the companies offering mRNA custom synthesis services.  A detailed competitiveness analysis of mRNA custom synthesis service providers.  A comprehensive assessment of the overall market landscape of mRNA contract manufacturing service providers, based on several relevant parameters.  An in-depth company competitiveness analysis of mRNA contract manufacturing service providers based in North America, Europe and Asia-Pacific.  A detailed overview of the current market landscape of kits available for synthesis of research grade mRNA.  A detailed product competitiveness analysis of the mRNA synthesis kits.  Elaborate profiles of key players engaged in the synthesis and manufacturing of mRNA (shortlisted based on strength of service portfolio).  Detailed profiles of the key mRNA synthesis kit providers (shortlisted based on strength of product portfolio).  A detailed assessment of completed, ongoing and planned clinical studies of mRNA therapeutics and vaccines.  An insight analysis of the recent partnerships inked between stakeholders engaged in this domain from 2014-2022  An in-depth analysis of over 35 mRNA-based therapeutics / vaccines developers that are likely to partner with mRNA contract manufacturing service providers.  A review of the various mRNA-focused initiatives undertaken by big pharma players (shortlisted on the basis of the revenues generated in 2021)  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Type of Product  Drug substances (APIs)  Drug products (FDFs)  Application Area  mRNA-based vaccines  mRNA-based therapeutics  Therapeutic Area  Infectious diseases  Oncological disorders  Other diseases  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa  Rest of the World Key companies covered in the report.  Aldevron  APExBIO  Biomay  bioSYNTHESIS  CELLSCRIPT  eTheRNA  Eurogentec  Jena Biosciences  New England Biolabs  Thermo Fisher Scientific  TriLink BioTechnologies To view more details on this report, click on the link https://www.rootsanalysis.com/reports/mrna-synthesis-and-manufacturing-market.html You may also be interested in the following titles: Cannabis Testing Market Decentralized Clinical Trials / Virtual Clinical Trials Market You may also like to learn what our experts are sharing in Roots educational series: Cell Therapy – The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological Disorders 4D Bioprinting Market: Key Trends About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #mRNASynthesisandManufacturingServicesMarket #mRNASynthesisandManufacturingServicesMarketSize #mRNAsynthesisservices #mRNAsynthesisandmanufacturingservices #mRNAbasedproducts